These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19139476)

  • 61. Genotype-guided warfarin therapy: Still of only questionable value two decades on.
    Shah RR
    J Clin Pharm Ther; 2020 Jun; 45(3):547-560. PubMed ID: 32168383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification and Enzymatic Activity Evaluation of a Novel
    Zhou XY; Lu XR; Li YH; Ma YQ; Zhao SW; Wang F; Xu RA; Hu GX; Cai JP
    Front Pharmacol; 2021; 12():619339. PubMed ID: 33643050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacogenomics: the influence of genomic variation on drug response.
    Thomas FJ; McLeod HL; Watters JW
    Curr Top Med Chem; 2004; 4(13):1399-409. PubMed ID: 15379653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Bayesian Estimation Framework for Pharmacogenomics Driven Warfarin Dosing: A Comparative Study.
    Öztaner SM; Temizel TT; Erdem SR; Özer M
    IEEE J Biomed Health Inform; 2015 Sep; 19(5):1724-33. PubMed ID: 25020183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacogenomics and warfarin.
    Anderson DC
    Am J Health Syst Pharm; 2009 Jan; 66(2):121. PubMed ID: 19139475
    [No Abstract]   [Full Text] [Related]  

  • 66. Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.
    French B; Joo J; Geller NL; Kimmel SE; Rosenberg Y; Anderson JL; Gage BF; Johnson JA; Ellenberg JH;
    Trials; 2010 Nov; 11():108. PubMed ID: 21083927
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin.
    Jensen BP; Chin PK; Roberts RL; Begg EJ
    Br J Clin Pharmacol; 2012 Nov; 74(5):797-805. PubMed ID: 22380743
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacogenomics of anticoagulants: steps toward personal dosage.
    Daly AK
    Genome Med; 2009 Jan; 1(1):10. PubMed ID: 19348697
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting.
    Zhang J; Wu T; Chen W; Fu J; Xia X; Chen L
    Front Pharmacol; 2019; 10():1527. PubMed ID: 32038232
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implications of pharmacogenetics for oral anticoagulants metabolism.
    Pérez-Andreu V; Roldán V; González-Conejero R; Hernández-Romero D; Vicente V; Marín F
    Curr Drug Metab; 2009 Jul; 10(6):632-42. PubMed ID: 19799531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Feasibility of implementing a comprehensive warfarin pharmacogenetics service.
    Nutescu EA; Drozda K; Bress AP; Galanter WL; Stevenson J; Stamos TD; Desai AA; Duarte JD; Gordeuk V; Peace D; Kadkol SS; Dodge C; Saraf S; Garofalo J; Krishnan JA; Garcia JG; Cavallari LH
    Pharmacotherapy; 2013 Nov; 33(11):1156-64. PubMed ID: 23864527
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Warfarin genotyping using three different platforms.
    Lefferts JA; Schwab MC; Dandamudi UB; Lee HK; Lewis LD; Tsongalis GJ
    Am J Transl Res; 2010 Jul; 2(4):441-6. PubMed ID: 20733952
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacogenetics: from bench to byte--an update of guidelines.
    Swen JJ; Nijenhuis M; de Boer A; Grandia L; Maitland-van der Zee AH; Mulder H; Rongen GA; van Schaik RH; Schalekamp T; Touw DJ; van der Weide J; Wilffert B; Deneer VH; Guchelaar HJ
    Clin Pharmacol Ther; 2011 May; 89(5):662-73. PubMed ID: 21412232
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Warfarin Pharmacogenetics: New Life for an Old Drug.
    Wen MS; Lee MT
    Acta Cardiol Sin; 2013 May; 29(3):235-42. PubMed ID: 27122712
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Testing of VKORC1 and CYP2C9 alleles to guide warfarin dosing. Test category: pharmacogenomic (treatment).
    Grossniklaus D
    PLoS Curr; 2010 Sep; 2():. PubMed ID: 20877452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Electrocatalytic drug metabolism by CYP2C9 bonded to a self-assembled monolayer-modified electrode.
    Yang M; Kabulski JL; Wollenberg L; Chen X; Subramanian M; Tracy TS; Lederman D; Gannett PM; Wu N
    Drug Metab Dispos; 2009 Apr; 37(4):892-9. PubMed ID: 19171677
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Warfarin pharmacogenomics.
    Li J; Wang S; Barone J; Malone B
    P T; 2009 Aug; 34(8):422-7. PubMed ID: 20140106
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetics of warfarin sensitivity in an emergency department population with thromboembolic.
    Johnson SW; Henderson S
    West J Emerg Med; 2011 Feb; 12(1):11-6. PubMed ID: 21691466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.
    Daly AK; Rettie AE; Fowler DM; Miners JO
    J Pers Med; 2017 Dec; 8(1):. PubMed ID: 29283396
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Time to revisit warfarin pharmacogenetics.
    Cavallari LH
    Future Cardiol; 2017 Nov; 13(6):511-513. PubMed ID: 28967279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.